Market Cap 985.39M
Revenue (ttm) 67.48M
Net Income (ttm) -278.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -412.97%
Debt to Equity Ratio 0.09
Volume 1,889,400
Avg Vol 1,786,636
Day's Range N/A - N/A
Shares Out 88.77M
Stochastic %K 92%
Beta 0.35
Analysts Strong Sell
Price Target $31.17

Company Profile

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabe...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 500 8800
Address:
4930 Directors Place, Suite 500, San Diego, United States
Rubener
Rubener Jul. 2 at 9:25 AM
0 · Reply
Rubener
Rubener Jul. 1 at 8:23 PM
0 · Reply
Flyingkitty
Flyingkitty Jul. 1 at 2:28 PM
0 · Reply
Donnybooy
Donnybooy Jul. 1 at 1:11 PM
0 · Reply
Oscarca
Oscarca Jun. 30 at 6:13 PM
0 · Reply
Flyingkitty
Flyingkitty Jun. 30 at 3:44 PM
$KURA Been quietly adding here over the last couple of months...
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 29 at 4:20 AM
$SLS $KURA dude the AML space is not that large thank God. For SLS to be worth $100+ makes no sense. Selling my shares and investing elsewhere soon 😉
3 · Reply
BRLondon
BRLondon Jun. 26 at 9:22 PM
$KURA Huge volume at the close. News on Monday?
1 · Reply
Fort_Knox_Investments
Fort_Knox_Investments Jun. 26 at 3:32 PM
0 · Reply
Rubener
Rubener Jun. 26 at 1:29 PM
$KURA I really believe we will see $20 and above this year
0 · Reply
Latest News on KURA
Kura Oncology Transcript: Status update

Jun 12, 2026, 8:00 AM EDT - 22 days ago

Kura Oncology Transcript: Status update


Kura Oncology Press release: Status update

Jun 12, 2026, 8:00 AM EDT - 22 days ago

Kura Oncology Press release: Status update


Kura Oncology Slides: Status update

Jun 12, 2026, 8:00 AM EDT - 22 days ago

Kura Oncology Slides: Status update


Kura Oncology Transcript: Investor update

Jun 3, 2026, 3:15 PM EDT - 4 weeks ago

Kura Oncology Transcript: Investor update


Kura Oncology Press release: Investor update

Jun 3, 2026, 3:15 PM EDT - 4 weeks ago

Kura Oncology Press release: Investor update


Kura Oncology Slides: Investor update

Jun 3, 2026, 3:15 PM EDT - 4 weeks ago

Kura Oncology Slides: Investor update


Kura Oncology Proxy statement: Proxy filing

May 26, 2026, 8:00 AM EDT - 5 weeks ago

Kura Oncology Proxy statement: Proxy filing


Kura Oncology reports Q1 EPS (83c), consensus (78c)

2026-05-12T21:25:48.000Z - 7 weeks ago

Kura Oncology reports Q1 EPS (83c), consensus (78c)


Kura Oncology Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Kura Oncology Earnings Call Transcript: Q1 2026


Kura Oncology Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Kura Oncology Earnings release: Q1 2026


Kura Oncology Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Kura Oncology Quarterly report: Q1 2026


Kura Oncology Reports First Quarter 2026 Financial Results

May 12, 2026, 4:02 PM EDT - 7 weeks ago

Kura Oncology Reports First Quarter 2026 Financial Results


Kura Oncology Slides: Corporate presentation

May 12, 2026, 4:00 PM EDT - 7 weeks ago

Kura Oncology Slides: Corporate presentation


Kura Oncology to Report First Quarter 2026 Financial Results

May 5, 2026, 7:30 AM EDT - 2 months ago

Kura Oncology to Report First Quarter 2026 Financial Results


Kura Oncology Transcript: Investor Update

Apr 17, 2026, 10:30 AM EDT - 2 months ago

Kura Oncology Transcript: Investor Update


Kura Oncology Press release: Investor Update

Apr 17, 2026, 10:30 AM EDT - 2 months ago

Kura Oncology Press release: Investor Update


Kura Oncology Slides: Investor Update

Apr 17, 2026, 10:30 AM EDT - 2 months ago

Kura Oncology Slides: Investor Update


Kura Oncology initiated with a Buy at Lake Street

2026-04-14T11:42:35.000Z - 2 months ago

Kura Oncology initiated with a Buy at Lake Street


Kura Oncology Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

Kura Oncology Proxy statement: Proxy filing


Kura Oncology Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

Kura Oncology Proxy statement: Proxy filing


Syndax assumed with a Buy at Jefferies

2026-03-30T13:08:09.000Z - 3 months ago

Syndax assumed with a Buy at Jefferies

SNDX


Kura Oncology price target lowered to $25 from $30 at Mizuho

2026-03-24T15:07:11.000Z - 3 months ago

Kura Oncology price target lowered to $25 from $30 at Mizuho


Kura Oncology price target lowered to $15 from $16 at UBS

2026-03-13T13:43:20.000Z - 4 months ago

Kura Oncology price target lowered to $15 from $16 at UBS


Kura Oncology price target raised to $30 from $29 at BofA

2026-03-06T14:25:12.000Z - 4 months ago

Kura Oncology price target raised to $30 from $29 at BofA


Kura Oncology price target lowered to $36 from $38 at Wedbush

2026-03-06T12:48:51.000Z - 4 months ago

Kura Oncology price target lowered to $36 from $38 at Wedbush


Kura Oncology Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:00 AM EST - 4 months ago

Kura Oncology Earnings Call Transcript: Q4 2025


Kura Oncology Annual report: Q4 2025

Mar 5, 2026, 8:00 AM EST - 4 months ago

Kura Oncology Annual report: Q4 2025


Kura Oncology Earnings release: Q4 2025

Mar 5, 2026, 8:00 AM EST - 4 months ago

Kura Oncology Earnings release: Q4 2025


Kura Oncology Slides: Corporate presentation

Mar 5, 2026, 7:00 AM EST - 4 months ago

Kura Oncology Slides: Corporate presentation


Kura Oncology reports Q4 EPS (92c), consensus (49c)

2026-03-05T11:36:05.000Z - 4 months ago

Kura Oncology reports Q4 EPS (92c), consensus (49c)


Kura Oncology management to meet with Citizens

2026-03-03T18:35:52.000Z - 4 months ago

Kura Oncology management to meet with Citizens


Kura Oncology price target lowered to $29 from $30 at BofA

2026-02-03T11:50:13.000Z - 5 months ago

Kura Oncology price target lowered to $29 from $30 at BofA


Kura Oncology Transcript: Status Update

Dec 8, 2025, 12:30 PM EST - 7 months ago

Kura Oncology Transcript: Status Update


Kura Oncology Press release: Status Update

Dec 8, 2025, 12:30 PM EST - 7 months ago

Kura Oncology Press release: Status Update


Kura Oncology Slides: Status Update

Dec 8, 2025, 12:30 PM EST - 7 months ago

Kura Oncology Slides: Status Update


Kura Oncology Transcript: FDA Announcement

Nov 13, 2025, 12:30 PM EST - 8 months ago

Kura Oncology Transcript: FDA Announcement


Kura Oncology Press release: FDA Announcement

Nov 13, 2025, 12:30 PM EST - 8 months ago

Kura Oncology Press release: FDA Announcement


US FDA approves Kura Oncology's blood cancer therapy

Nov 13, 2025, 10:32 AM EST - 8 months ago

US FDA approves Kura Oncology's blood cancer therapy


Kura Oncology to Participate in Upcoming Investor Conference

Nov 12, 2025, 4:05 PM EST - 8 months ago

Kura Oncology to Participate in Upcoming Investor Conference


Kura Oncology Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Kura Oncology Earnings Call Transcript: Q3 2025


Kura Oncology Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Kura Oncology Quarterly report: Q3 2025


Kura Oncology Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Kura Oncology Earnings release: Q3 2025


Kura Oncology Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 6:31 AM EST - 8 months ago

Kura Oncology Reports Third Quarter 2025 Financial Results


Kura Oncology to Report Third Quarter 2025 Financial Results

Oct 28, 2025, 4:01 PM EDT - 8 months ago

Kura Oncology to Report Third Quarter 2025 Financial Results


Kura Oncology Transcript: ESMO Congress 2025

Oct 18, 2025, 1:30 PM EDT - 9 months ago

Kura Oncology Transcript: ESMO Congress 2025


Kura Oncology Slides: FY 2025

Oct 18, 2025, 1:30 PM EDT - 9 months ago

Kura Oncology Slides: FY 2025


Kura Oncology Transcript: UBS Virtual Oncology Day

Oct 1, 2025, 2:30 PM EDT - 9 months ago

Kura Oncology Transcript: UBS Virtual Oncology Day


Kura Oncology Transcript: Study Update

Sep 16, 2025, 4:30 PM EDT - 10 months ago

Kura Oncology Transcript: Study Update


Kura Oncology Press release: Study Update

Sep 16, 2025, 4:30 PM EDT - 10 months ago

Kura Oncology Press release: Study Update


Kura Oncology Slides: Study Update

Sep 16, 2025, 4:30 PM EDT - 10 months ago

Kura Oncology Slides: Study Update


Kura Oncology Slides: Corporate Presentation

Sep 7, 2025, 6:00 PM EDT - 10 months ago

Kura Oncology Slides: Corporate Presentation


Kura Oncology Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Kura Oncology Earnings Call Transcript: Q2 2025


Kura Oncology Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Kura Oncology Quarterly report: Q2 2025


Kura Oncology Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Kura Oncology Earnings release: Q2 2025


Kura Oncology Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 11 months ago

Kura Oncology Reports Second Quarter 2025 Financial Results


Kura Oncology to Report Second Quarter 2025 Financial Results

Jul 31, 2025, 7:30 AM EDT - 1 year ago

Kura Oncology to Report Second Quarter 2025 Financial Results


Kura Oncology Transcript: Status Update

Jun 18, 2025, 4:30 PM EDT - 1 year ago

Kura Oncology Transcript: Status Update


Kura Oncology Slides: Status Update

Jun 18, 2025, 4:30 PM EDT - 1 year ago

Kura Oncology Slides: Status Update


Kura Oncology Slides: FY 2025

Jun 2, 2025, 7:30 PM EDT - 1 year ago

Kura Oncology Slides: FY 2025


Kura Oncology Earnings Call Transcript: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Kura Oncology Earnings Call Transcript: Q1 2025


Kura Oncology Quarterly report: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Kura Oncology Quarterly report: Q1 2025


Kura Oncology Earnings release: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Kura Oncology Earnings release: Q1 2025


Kura Oncology Reports First Quarter 2025 Financial Results

May 1, 2025, 4:05 PM EDT - 1 year ago

Kura Oncology Reports First Quarter 2025 Financial Results


Kura Oncology Slides: Corporate Presentation

May 1, 2025, 7:00 AM EDT - 1 year ago

Kura Oncology Slides: Corporate Presentation


Kura Oncology to Report First Quarter 2025 Financial Results

Apr 24, 2025, 7:30 AM EDT - 1 year ago

Kura Oncology to Report First Quarter 2025 Financial Results


Kura Oncology Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Kura Oncology Proxy statement: Proxy Filing


Kura Oncology Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Kura Oncology Proxy statement: Proxy Filing


Kura Oncology Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Kura Oncology Earnings Call Transcript: Q4 2024


Kura Oncology Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Kura Oncology Annual report: Q4 2024


Kura Oncology Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Kura Oncology Earnings release: Q4 2024


Kura Oncology Slides: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Kura Oncology Slides: Q4 2024


Rubener
Rubener Jul. 2 at 9:25 AM
0 · Reply
Rubener
Rubener Jul. 1 at 8:23 PM
0 · Reply
Flyingkitty
Flyingkitty Jul. 1 at 2:28 PM
0 · Reply
Donnybooy
Donnybooy Jul. 1 at 1:11 PM
0 · Reply
Oscarca
Oscarca Jun. 30 at 6:13 PM
0 · Reply
Flyingkitty
Flyingkitty Jun. 30 at 3:44 PM
$KURA Been quietly adding here over the last couple of months...
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 29 at 4:20 AM
$SLS $KURA dude the AML space is not that large thank God. For SLS to be worth $100+ makes no sense. Selling my shares and investing elsewhere soon 😉
3 · Reply
BRLondon
BRLondon Jun. 26 at 9:22 PM
$KURA Huge volume at the close. News on Monday?
1 · Reply
Fort_Knox_Investments
Fort_Knox_Investments Jun. 26 at 3:32 PM
0 · Reply
Rubener
Rubener Jun. 26 at 1:29 PM
$KURA I really believe we will see $20 and above this year
0 · Reply
badprecog
badprecog Jun. 26 at 1:12 PM
$KURA Lets go!!! 100% confident we havea blockbuster!
1 · Reply
Rubener
Rubener Jun. 24 at 8:34 PM
0 · Reply
quickaspeter
quickaspeter Jun. 24 at 2:45 PM
$KURA I like your thinking…let’s go! 💥🚀💰💰💰
0 · Reply
badprecog
badprecog Jun. 24 at 2:02 PM
$KURA Nice!
0 · Reply
badprecog
badprecog Jun. 23 at 3:12 PM
$KURA In case you missed it...
0 · Reply
badprecog
badprecog Jun. 23 at 1:36 PM
$KURA Anyone that looks at this stock will buy it. Just a matter of eyeballs. $1.1B in successful R&D for free.
2 · Reply
Rubener
Rubener Jun. 22 at 8:31 PM
0 · Reply
badprecog
badprecog Jun. 22 at 8:02 PM
$KURA Great day all!
0 · Reply
revuelto
revuelto Jun. 22 at 4:27 PM
$KURA is this the next name in line for a buyout? 🎉
2 · Reply
badprecog
badprecog Jun. 22 at 2:31 PM
$KURA Such a great company! And your basically getting drugs with $1.1B in R&D for free right now when you factor in the milestone payments coming due! Unreal!
0 · Reply
badprecog
badprecog Jun. 18 at 8:01 PM
$KURA Slow and steady wins the race! Lets get past $12!
0 · Reply
Rubener
Rubener Jun. 18 at 4:52 PM
0 · Reply